A matched propensity score study of embryo morphokinetics following gonadotropin-releasing hormone agonist versus human chorionic gonadotropin trigger. 2020

Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
Infertility and IVF Unit, Helen Schneider Hospital for Women, Rabin Medical Center, Beilinson Hospital, 4941492, Petah Tikva, Israel. orongalia@gmail.com.

OBJECTIVE To compare morphokinetic parameters and quality of embryos derived from GnRH antagonist ICSI cycles triggered either with GnRH agonist or standard hCG between matched groups of patients. METHODS Morphokinetic parameters of embryos derived from matched first GnRH antagonist ICSI cycles triggered by GnRH agonist or standard hCG between 2013 and 2016 were compared. Matching was performed for maternal age, peak estradiol levels, and number of oocytes retrieved. Outcome measures were: time to pronucleus fading (tPNf), cleavage timings (t2-t8), synchrony of the second and third cycles (S2 and S3), duration of the second and third cycle (CC2 and CC3), optimal cell cycle division parameters, and known implantation data (KID) scoring for embryo quality. Multivariate linear and logistic regression analyses were performed for confounding factors. RESULTS We analyzed 824 embryos from 84 GnRH agonist trigger cycles and 746 embryos from 84 matched hCG trigger cycles. Embryos derived from the cycles triggered with hCG triggering cleaved faster than those deriving from GnRH agonist trigger. The differences were significant throughout most stages of embryo development (t3-t6), and a shorter second cell cycle duration of the hCG trigger embryos was observed. There was no difference in synchrony of the second and third cell cycles and the optimal cell cycle division parameters between the two groups, but there was a higher percentage of embryos without multinucleation in the hCG trigger group (27.8% vs. 21.6%, p < 0.001). CONCLUSIONS The type of trigger in matched antagonist ICSI cycles was found to affect early embryo cleavage times but not embryo quality.

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D010064 Embryo Implantation Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage. Blastocyst Implantation,Decidual Cell Reaction,Implantation, Blastocyst,Nidation,Ovum Implantation,Blastocyst Implantations,Decidual Cell Reactions,Embryo Implantations,Implantation, Embryo,Implantation, Ovum,Implantations, Blastocyst,Implantations, Embryo,Implantations, Ovum,Nidations,Ovum Implantations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
July 1994, Fertility and sterility,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
September 2016, Fertility and sterility,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
December 2021, Reproductive sciences (Thousand Oaks, Calif.),
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
September 2016, The journal of obstetrics and gynaecology research,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
December 2016, JBRA assisted reproduction,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
March 1995, Journal of assisted reproduction and genetics,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
January 2018, International journal of reproductive biomedicine,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
March 2022, Obstetrics & gynecology science,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
August 2014, Fertility and sterility,
Galia Oron, and Onit Sapir, and Avital Wertheimer, and Yoel Shufaro, and Roni Bar-Gil, and Tamar Margalit, and Ekaterina Shlush, and Avi Ben-Haroush
January 2016, Journal of human reproductive sciences,
Copied contents to your clipboard!